TP53 and plasma cell myeloma: There are many algorithms to determine how to define high-risk myeloma, and the genomic markers include t(4;14), t(14;16), gain 1q21 (CKS1B), del 1p32 (CDKN2C), and del 17p13 (TP53) [1–4].